Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Filed Balance Sheet (Tables)

v3.22.1
Restatement of Previously Filed Balance Sheet (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Previously Filed Balance Sheet  
Summarize the effect of the revision to the Post-IPO Balance Sheet

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

​

​

    

​

​

As of February 2, 2021

​

Reported

​

Adjustment

​

As Restated

Total assets

​

$

289,785,365

​

$

—

​

$

289,785,365

Derivative warrant liabilities

​

 

—

​

 

10,638,000

​

 

10,638,000

Total liabilities

​

$

10,704,851

​

$

10,638,000

​

$

21,342,851

Class A ordinary shares subject to possible redemption

​

 

274,080,510

​

 

13,419,490

​

 

287,500,000

Preferred shares

​

 

—

​

 

—

​

 

—

Class A ordinary shares

​

 

214

​

 

(134)

​

 

80

Class B ordinary shares

​

 

719

​

 

—

​

 

719

Additional paid-in capital

​

 

5,030,402

​

 

(5,030,402)

​

 

—

Accumulated deficit

​

 

(31,331)

​

 

(19,026,954)

​

 

(19,058,285)

Total shareholders’ equity (deficit)

​

$

5,000,004

​

$

(24,057,490)

​

 

(19,057,486)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)

​

$

289,785,365

​

$

—

​

$

289,785,365